Related Experiment Videos
Technetium-99m tetrofosmin imaging in malignant lymphomas.
O Schillaci1, A M Filippis, A P Anselmo
1Tor Vergata University, Rome, Italy. oschil@tiscalinet.it
Tumori
|October 9, 2002
Summary
99mTc tetrofosmin (TF) scintigraphy effectively detects supradiaphragmatic lymphoma lesions in untreated patients. Serial TF imaging may also monitor treatment response, though further studies are required.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Lymphomas are cancers of the lymphatic system.
- Accurate staging and monitoring of lymphoma are crucial for effective treatment.
- Diagnostic imaging plays a vital role in lymphoma management.
Purpose of the Study:
- To evaluate the diagnostic utility of 99mTc tetrofosmin (TF) scintigraphy.
- To assess TF scintigraphy's effectiveness in detecting supradiaphragmatic lymphoma lesions.
- To explore the potential of TF scintigraphy in monitoring treatment response.
Main Methods:
- Seventeen patients with Hodgkin's disease or non-Hodgkin's lymphoma underwent TF scintigraphy.
- Planar and SPECT imaging of the neck and chest were performed.
- Results were compared with CT scans in a blinded manner.
Main Results:
- TF imaging identified pathological uptake in 16 of 17 untreated patients, detecting 38 sites.
- Scintigraphy detected 22 of 24 CT-identified lesions and revealed 16 previously unknown tumor sites.
- Post-treatment scans showed a reduction in visualized lesions, suggesting potential for monitoring therapy response.
Conclusions:
- 99mTc tetrofosmin (TF) scintigraphy is effective for depicting supradiaphragmatic lymphoma in untreated patients.
- Serial TF imaging may be valuable for monitoring lymphoma treatment response.
- Larger studies are needed to confirm TF scintigraphy's role in therapy follow-up.